Correlation Between Antibe Therapeutics and Reunion Neuroscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Antibe Therapeutics and Reunion Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibe Therapeutics and Reunion Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antibe Therapeutics and Reunion Neuroscience, you can compare the effects of market volatilities on Antibe Therapeutics and Reunion Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibe Therapeutics with a short position of Reunion Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibe Therapeutics and Reunion Neuroscience.

Diversification Opportunities for Antibe Therapeutics and Reunion Neuroscience

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Antibe and Reunion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antibe Therapeutics and Reunion Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reunion Neuroscience and Antibe Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibe Therapeutics are associated (or correlated) with Reunion Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reunion Neuroscience has no effect on the direction of Antibe Therapeutics i.e., Antibe Therapeutics and Reunion Neuroscience go up and down completely randomly.

Pair Corralation between Antibe Therapeutics and Reunion Neuroscience

If you would invest  112.00  in Reunion Neuroscience on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Reunion Neuroscience or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.8%
ValuesDaily Returns

Antibe Therapeutics  vs.  Reunion Neuroscience

 Performance 
       Timeline  
Antibe Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Antibe Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Antibe Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Reunion Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reunion Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Reunion Neuroscience is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Antibe Therapeutics and Reunion Neuroscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Antibe Therapeutics and Reunion Neuroscience

The main advantage of trading using opposite Antibe Therapeutics and Reunion Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibe Therapeutics position performs unexpectedly, Reunion Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will offset losses from the drop in Reunion Neuroscience's long position.
The idea behind Antibe Therapeutics and Reunion Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios